Concepedia
Statistics
Publications
1
Citations
35
H-Index
Active since
2018
Affiliations
Charles River Laboratories (Germany)(Current)
Matt Labenski is an author at Charles River Laboratories (Germany).
Publications per year
2018–2018
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
Ida Aronchik, Yumin Dai, Matt Labenski et al. · Molecular Cancer Research · 2018 · 35 citations · Full text
1–1 of 1